Is regadenoson an appropriate stressor for MPI in patients with LBBB or pacemakers?

被引：0
|
作者：
Thomas, Gregory [1 ]
Kinser, Carissa [2 ]
机构：
[1] Mission Internal Med Grp, Mission Viejo, CA USA
[2] Astellas Pharma Global Dev, Deerfield, IL USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1730
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Hemodynamic Effects of Regadenoson Administration With Respect to MPI Findings: 6 Month Institutional Experience in Greece
    Koutsikos, J.
    Angelidis, G.
    Ilia, E.
    Vogiatzis, M.
    Mamarelis, J.
    Stefanidis, V.
    Zafirakis, A.
    Lazaridis, K.
    Dimakopoulos, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S580 - S581
  • [22] RETRACTED: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI (Retracted Article)
    Doran, Jesse A.
    Sajjad, Waseem
    Schneider, Marabel D.
    Gupta, Rohit
    Mackin, Maria L.
    Schwartz, Ronald G.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (03) : 1062 - 1070
  • [23] PATIENTS AND PACEMAKERS
    ILTIS, R
    IEEE SPECTRUM, 1982, 19 (01) : 10 - 10
  • [24] Proportion of Patients with Implanted Permanent Pacemakers with Atrial Fibrillation Receiving Appropriate Medical Prophylaxis in North Wales
    Jones, Matthew
    Williams, Edgar M.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2012, 35 (08): : 935 - 942
  • [25] Can current minute ventilation rate adaptive pacemakers provide appropriate chronotropic response in pediatric patients?
    Cabrera, ME
    Portzline, G
    Aach, S
    Condie, C
    Dorostkar, P
    Mianulli, M
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2002, 25 (06): : 907 - 914
  • [26] Blunting of the Heart Rate Response to Adenosine and Regadenoson in Relation to Hyperglycemia and the Metabolic Syndrome in the ADVNACE MPI Trials
    Hage, Fadi G.
    Franks, Billy
    Heo, Jaekyeong
    Belardinelli, Luiz
    Blackburn, Brent
    Wang, Whedy
    Iskandrian, Ami E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A295 - A296
  • [27] Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?
    Miller, Erica O.
    Schwartz, Ronald G.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (01) : 119 - 121
  • [28] Sympathetic innervation in patients with LBBB using MIBG
    Koutelou, M
    Theodorakos, AT
    Athanassopoulos, G
    Tsapaki, V
    Kouzoumi, A
    Cokkinos, V
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1205 - 1205
  • [29] TL-201 SPECT FOR PATIENTS WITH LBBB
    SCHWARZ, J
    MOORE, WH
    PRICE, E
    MASSUMI, GA
    DHEKNE, RD
    HALL, RJ
    LONG, SE
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (02) : 279 - 279
  • [30] Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?
    Erica O. Miller
    Ronald G. Schwartz
    Journal of Nuclear Cardiology, 2017, 24 : 119 - 121
12345